BioNTech Tax Provision from 2010 to 2024

BNTX Stock  USD 117.20  1.19  1.01%   
BioNTech Tax Provision yearly trend continues to be fairly stable with very little volatility. Tax Provision will likely drop to about 243 M in 2024. Tax Provision is the amount set aside by BioNTech SE to cover any estimated taxes for the current period. It reflects BioNTech's expected tax liabilities. View All Fundamentals
 
Tax Provision  
First Reported
2018-06-30
Previous Quarter
M
Current Value
-39.4 M
Quarterly Volatility
544 M
 
Covid
Check BioNTech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioNTech's main balance sheet or income statement drivers, such as Tax Provision of 243 M, Net Interest Income of 367.2 M or Interest Income of 375.5 M, as well as many indicators such as Price To Sales Ratio of 5.77, Dividend Yield of 0.0111 or PTB Ratio of 1.2. BioNTech financial statements analysis is a perfect complement when working with BioNTech Valuation or Volatility modules.
  
Check out the analysis of BioNTech Correlation against competitors.

Latest BioNTech's Tax Provision Growth Pattern

Below is the plot of the Tax Provision of BioNTech SE over the last few years. It is the amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities. BioNTech's Tax Provision historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioNTech's overall financial position and show how it may be relating to other accounts over time.
Tax Provision10 Years Trend
Slightly volatile
   Tax Provision   
       Timeline  

BioNTech Tax Provision Regression Statistics

Arithmetic Mean574,140,133
Geometric Mean1,503,348
Coefficient Of Variation255.79
Mean Deviation950,042,631
Median45,000
Standard Deviation1,468,568,517
Sample Variance2156693.5T
Range4.9B
R-Value0.43
Mean Square Error1896861.1T
R-Squared0.18
Significance0.11
Slope140,592,050
Total Sum of Squares30193708.9T

BioNTech Tax Provision History

2024243 M
2023255.8 M
20223.5 B
20214.8 B
2020-161 M
2019-268 K
2018600 K

About BioNTech Financial Statements

BioNTech investors use historical fundamental indicators, such as BioNTech's Tax Provision, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioNTech. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Tax Provision255.8 M243 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BioNTech Stock Analysis

When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.